Search
CSPC Pharmaceutical Group: Has Received a $25 Million R&D Milestone Payment from AstraZeneca
2 hour ago /
Read about 0 minute
Author：小编
CSPC Pharmaceutical Group (HK1093) announced that it received a $25 million R&D milestone payment from AstraZeneca (AZN) on July 10, 2026. Previously, CSPC Pharmaceutical Group had already received the initial payment under this agreement on May 29. According to the agreement between the two parties, they will jointly develop innovative long-acting peptide drugs by leveraging CSPC Pharmaceutical Group's long-acting delivery technology platform and AI-driven peptide drug discovery platform.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
